Skip to content

Home | Site Map | Privacy Policy

Coupon

Available in capsule or powder
for oral suspension

Treatment Options & Heartburn Relief

Heartburn, acid reflux (GERD) treatments: from short-term heartburn relief to 24-hour acid control

A lot of people select GERD treatments for themselves. For instance, you can walk into a drug store seeking a heartburn treatment or acid reflux treatment and buy antacids such as Tums®, H2 blockers such as Pepcid AC®, or proton pump inhibitors such as PrilosecOTC® without a prescription. However, you should still see your doctor to discuss GERD treatments for your acid reflux symptoms. Frequent heartburn can be a sign of acid reflux disease, which can lead to other more serious disease like erosive esophagitis.

Below you will find various options for heartburn treatment and GERD/acid reflux treatment discussed in further detail.

Antacids

Antacids neutralize the acid in your stomach and provide prompt heartburn treatment and heartburn relief. Examples include Tums® and Rolaids®.

H2 blockers

H2 blockers block stomach acid production and provide acid reflux treatment and relief of heartburn symptoms. However, they do not block acid as completely as proton pump inhibitors. Examples include Tagamet HB 200® and Pepcid AC®.

Proton pump inhibitors

Proton pump inhibitors are highly effective treatments and are used for long-term GERD or acid reflux treatment. Proton pump inhibitors control stomach acid and provide heartburn relief. ZEGERID is the First and Only Immediate-Release proton pump inhibitor, providing rapid release of the active ingredients and up to 24-hour acid control and heartburn relief.

Tums is a trademark of GlaxoSmithKline; Rolaids is a trademark of Pfizer Inc; Tagament HB 200 is a trademark of GlaxoSmithKline; Pepcid AC is a trademark of Johnson & Johnson-Merck Consumer Pharmaceuticals; PrilosecOTC is a trademark of Proctor & Gamble.


Next page: Heartburn medicines: Why choose ZEGERID?


Your Heartburn | Acid Reflux Symptoms | Acid Reflux Disease | Why Choose ZEGERID? |
For ZEGERID Patients | Seeing Your Doctor | Important Safety Information

Product Description
ZEGERID contains omeprazole, a proton pump inhibitor (PPI), and sodium bicarbonate, an antacid.

Important Safety Information about ZEGERID
ZEGERID is indicated for the treatment of heartburn and other symptoms of acid reflux disease. ZEGERID is used to treat and maintain the healing of erosive esophagitis, which may result from acid reflux. ZEGERID is also indicated for the short-term treatment of active duodenal ulcer and of active benign gastric ulcer.

Side effects of ZEGERID include headache, diarrhea and abdominal pain. Relief of your symptoms while on ZEGERID does not rule out that other serious stomach conditions may exist.

ZEGERID Capsules contain 303 mg of sodium per dose. ZEGERID Powder for Oral Suspension contains 460 mg of sodium per dose. The sodium is in the form of sodium bicarbonate and these amounts should be taken into consideration by anyone on a sodium-restricted diet. People with metabolic alkalosis and hypocalcemia should not take sodium bicarbonate.

ZEGERID Capsules and ZEGERID Powder for Oral Suspension have the same amount of sodium bicarbonate in both the 20mg and 40mg dosages. Two 20mg doses are not equivalent to one 40mg dose, and two 20mg doses should not be used in place of one 40mg dose.

ZEGERID should not be taken by anyone with a known hypersensitivity to any component of the formulation.

To learn more about ZEGERID, see full prescribing information and talk with your doctor.

Please consult with your healthcare professional to see if ZEGERID is right for you. The content of this Web site is not a substitute for professional medical advice and should not be interpreted as treatment recommendations or relied on for medical diagnosis or treatment. Please see complete Legal Disclaimer.

Nexium is a trademark of AstraZeneca LP; Prevacid is a trademark of Tap Pharmaceutical Products, Inc.; Protonix is a trademark of Wyeth Pharmaceuticals Inc.; Prilosec is a trademark of Astra Merck Inc.; Aciphex is a trademark of Eisai Co., Ltd.